Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia

BACKGROUND: Carbapenem is frequently used when gram negative bacilli (GNB) bacteremia is detected especially in neutropenic patients. Consequently, appropriate treatment could be delayed in GNB bacteremia cases involving organisms which are not susceptible to carbapenem (carba-NS), resulting in a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Dong Hoon, Shin, Dong-Yeop, Kang, Chang Kyung, Park, Suhyeon, Park, Jieun, Jun, Kang Il, Kim, Taek Soo, Koh, Youngil, Hong, Jun Shik, Choe, Pyoeng Gyun, Park, Wan Beom, Kim, Nam-Joong, Yoon, Sung-soo, Kim, Inho, Oh, Myoung-don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282079/
https://www.ncbi.nlm.nih.gov/pubmed/32517658
http://dx.doi.org/10.1186/s12879-020-05131-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282079/
https://www.ncbi.nlm.nih.gov/pubmed/32517658
http://dx.doi.org/10.1186/s12879-020-05131-2

Ejemplares similares